The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer

46Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We aimed to investigate the expression of caveolin- 1, -2, -3, and platelet-derived growth factor (PDGF) β receptor in breast cancer cells and stroma by immunohistochemistry and to analyze their implications. The expression rates of stromal caveolin-2 and PDGF β receptor increased as the tumor progressed from ductal carcinoma in situ to microinvasive ductal carcinoma, intraductal component of invasive ductal carcinoma (IDC), and IDC (p<0.001). The expression loss of caveolin-1 in tumor stroma of IDC correlated with high tumor stage (p<0.001), high nodal stage (p=0.011), high cancer stage (p=0.005), estrogen receptor negativity (p=0.003), and tumor recurrence (p=0.003). In addition, the expression loss of caveolin-1 in tumor stroma was correlated with a shorter disease-free survival and an overall survival (p<0.001). In conclusion, the loss of stromal caveolin-1 is related to poor prognosis in IDC. © International Society of Oncology and BioMarkers (ISOBM) 2011.

Cite

CITATION STYLE

APA

Koo, J. S., Park, S., Kim, S. I., Lee, S., & Park, B. W. (2011). The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer. Tumor Biology, 32(4), 787–799. https://doi.org/10.1007/s13277-011-0181-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free